Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial.

PMID: 36877502
Journal: JAMA Internal Medicine
Year: 2023
Reference: JAMA Intern Med. 2023 May 1;183(5):407-415. doi: 10.1001/jamainternmed.2023.0047.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonso, Fernando; Ariza-Sole, Albert; Barrabes, Jose A; Bueno, Hector; Calvo, Elena; Carol, Antoni; Diez-Villanueva, Pablo; Dominguez-Perez, Laura; Elizaga, Jaime; Formiga, Francesc et al.
DOI: 10.1001/jamainternmed.2023.0047

Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting.

PMID: 36720652
Journal: European Journal of Internal Medicine
Year: 2023
Reference: Eur J Intern Med. 2023 May;111:140-142. doi: 10.1016/j.ejim.2023.01.023. Epub 2023 Jan 30.
Impact factor:
Publication type: Letter or abstract
Authors: Blanco, I; Cruz Utrilla, A; Del Pozo, R; Escribano-Subias, P; Lopez-Meseguer, M et al.
DOI: 10.1016/j.ejim.2023.01.023

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

PMID: 37434782
Journal: Frontiers in Cellular and Infection Microbiology
Year: 2023
Reference: Front Cell Infect Microbiol. 2023 Jun 26;13:1187999. doi: 10.3389/fcimb.2023.1187999. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Antela, Antonio; Arbones, Laia; Barrufet, Pilar; Boix, Vicente; Callejo, Anna Marino; Casadella, Maria; Cervanntes, Sara; Chamorro, Anna; Curran, Adria; Del Mar Gutierrez, Maria et al.
DOI: 10.3389/fcimb.2023.1187999

Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial.

PMID: 36995731
Journal: JAMA Oncology
Year: 2023
Reference: JAMA Oncol. 2023 May 1;9(5):656-663. doi: 10.1001/jamaoncol.2023.0056.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez, Rosa; Blay, Jean-Yves; Casali, Paolo G; Cruz Jurado, Josefina; Dei Tos, Angelo P; Fabbroni, Chiara; Gronchi, Alessandro; Gutierrez, Antonio; Hindi, Nadia; Italiano, Antoine et al.
DOI: 10.1001/jamaoncol.2023.0056

Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study.

PMID: 36777363
Journal: Therapeutic Advances in Gastroenterology
Year: 2023
Reference: Therap Adv Gastroenterol. 2023 Feb 9;16:17562848231153560. doi: 10.1177/17562848231153560. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Angel, Ponferrada Diaz; Beatriz, Lopez Cauce; Benito, Velayos Jimenez; Claudia, Herrera de Guise; Claudia, Herrera de Guise; Esteban, Fuentes-Valenzuela; Federico, Arguelles-Arias; Francisco, Mesonero Gismero; Lilyan, Kolle Casso; Luigi, Melcarne et al.
DOI: 10.1177/17562848231153560

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.

PMID: 37684497
Journal: CNS DRUGS
Year: 2023
Reference: CNS Drugs. 2023 Sep 9. doi: 10.1007/s40263-023-01033-4.
Impact factor:
Publication type: Paper in international publication
Authors: Besson, Herve; Chinn, Chris; D'Souza, Wendyl; Daniels, Tony; Faught, Edward; Floricel, Florin; Friesen, David; Insuga, Victor Soto; Klein, Pavel; Laloyaux, Cedric et al.
DOI: 10.1007/s40263-023-01033-4

Effectiveness of an online multicomponent program (FATIGUEWALK) for chronic fatigue syndrome: A randomized controlled trial.

PMID: 38127508
Journal: HEALTH PSYCHOLOGY
Year: 2023
Reference: Health Psychol. 2023 Dec 21. doi: 10.1037/hea0001346.
Impact factor:
Publication type: Paper in international publication
Authors: Auer, William; Borras, Xavier; Feliu-Soler, Albert; Ferres, Sonia; Luciano, Juan V; Navarrete, Jaime; Neblett, Randy; Nieto, Ruben; Sanmartin-Sentanes, Ramon; Serrat, Mayte et al.
DOI: 10.1037/hea0001346

Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post-COVID-19 sequelae: A randomized controlled trial.

PMID: 38009852
Journal: SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS
Year: 2023
Reference: Scand J Med Sci Sports. 2023 Nov 27. doi: 10.1111/sms.14543.
Impact factor:
Publication type: Paper in international publication
Authors: Del Carmen, Amin; Garnacho-Castano, Manuel V; Len, O; Miravitlles, Marc; Moreno, Eva; Pleguezuelos, Eulogio; Serra, Mateu; Villamarin, M et al.
DOI: 10.1111/sms.14543

Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.

PMID: 36396142
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2023
Reference: Eur Respir J. 2023 Mar 2;61(3):2201426. doi: 10.1183/13993003.01426-2022. Print 2023 Mar.
Impact factor:
Publication type: Paper in international publication
Authors: Adell-Serrano, Berta; Aguilera, Luciano; Amaya-Villar, Rosario; Anon, Jose Manuel; Barbe, Ferran; Barbera, Carme; Barberan, Jose; Barbeta, Enric; Blandino, Aaron; Boado, Maria Victoria et al.
DOI: 10.1183/13993003.01426-2022

Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENITS).

PMID: 38110225
Journal: ACTA PSYCHIATRICA SCANDINAVICA
Year: 2023
Reference: Acta Psychiatr Scand. 2023 Dec 18. doi: 10.1111/acps.13643.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Cristina; Back, Magnus; Beghin, Delphine; Bera, Annie Pierre Jonville; Bermejo-Sanchez, Eva; Bosch, Montserrat; Brida, Margarita; Cassina, Matteo; Chieffo, Alaide; Chouchana, Laurent et al.
DOI: 10.1111/acps.13643

Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma.

PMID: 37496871
Journal: Open Respiratory Archives
Year: 2023
Reference: Open Respir Arch. 2023 Jan 3;5(2):100231. doi: 10.1016/j.opresp.2022.100231. eCollection 2023 Apr-Jun.
Impact factor:
Publication type: Review in international publication
Authors: Canete, Conxa; Domingo, Christian; Martinez Rivera, Carlos; Munoz, Xavier; Plaza, Vicente et al.
DOI: 10.1016/j.opresp.2022.100231

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

PMID: 37027155
Journal: JAMA Network Open
Year: 2023
Reference: JAMA Netw Open. 2023 Apr 3;6(4):e237243. doi: 10.1001/jamanetworkopen.2023.7243.
Impact factor:
Publication type: Paper in international publication
Authors: Abdilla-Bonias, Noelia; Alende-Sixto, Rosario; Alvarez-Suarez, Ana Maria; Alvarez-Troncoso, Jorge; Andrade-Pina, Ariadna Helena; Arevalo, Coral; Argibay, Ana Belen; Arnaez, Ruben; Arnalich, Francisco; Bara, Nuria et al.
DOI: 10.1001/jamanetworkopen.2023.7243

Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.

PMID: 37964032
Journal: Gastric Cancer
Year: 2023
Reference: Gastric Cancer. 2023 Nov 15. doi: 10.1007/s10120-023-01443-9.
Impact factor:
Publication type: Paper in international publication
Authors: Abate, Emmanuele; Abdallah, Hussein; Adinolfi, Elvira; Agnesi, Stefano; Aguzzi, Daniele; Aisoni, Filippo; Albertini, Nicola; Allaix, Marco E; Altieri, Caterina; Amato, Antonio et al.
DOI: 10.1007/s10120-023-01443-9

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

PMID: 37016556
Journal: HIV MEDICINE
Year: 2023
Reference: HIV Med. 2023 Apr 4. doi: 10.1111/hiv.13489.
Impact factor:
Publication type: Paper in international publication
Authors: Casado, J L; Castano, M; de la Torre, J; Fanjul, F; Farinas, C; Galindo, M J; Gomez-Ayerbe, C; Hidalgo, C; Montero, M; Montes, M L et al.
DOI: 10.1111/hiv.13489

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

PMID: 37962077
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
Impact factor:
Publication type: Paper in international publication
Authors: Addy, Carol; Akarca, Ulus S; Allende, Daniela S; Allende, Daniela S; Alvares-da-Silva, Mario Reis; Amaddeo, Giuliana; Andreone, Pietro; Argemi, Josepmaria; Argemi, Josepmaria; Arrese, Marco et al.
DOI: 10.1056/NEJMoa2306185

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.

PMID: 38102535
Journal: BMC Neurology
Year: 2023
Reference: BMC Neurol. 2023 Dec 15;23(1):441. doi: 10.1186/s12883-023-03477-z.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Palomo, B; Aran, B; Castano, J; Ettrup, Anders; Florea, Ioana; Jansson, Gary; Kuebler, B; Luo, Guogang; Pozo-Rosich, Patricia; Querol Giner, S et al.
DOI: 10.1186/s12883-023-03477-z

Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study.

PMID: 36535300
Journal: Lancet Respiratory Medicine
Year: 2023
Reference: Lancet Respir Med. 2023 Apr;11(4):354-366. doi: 10.1016/S2213-2600(22)00437-4. Epub 2022 Dec 16.
Impact factor:
Publication type: Paper in international publication
Authors: Bauer, Todd M; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Iadeluca, Laura; Jassem, Jacek; Kim, Dong-Wan; Liu, Geoffrey; Lopez, Froylan Lopez; Mazieres, Julien et al.
DOI: 10.1016/S2213-2600(22)00437-4

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.

PMID: 36680880
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2023
Reference: Eur J Cancer. 2023 Mar;181:188-197. doi: 10.1016/j.ejca.2022.12.013. Epub 2022 Dec 27.
Impact factor:
Publication type: Paper in international publication
Authors: Arance, Ana; Bai, Kun; Balko, Justin M; Blum, Steven M; Buchbinder, Elizabeth I; Carlino, Matteo S; Da Silva, Ines P; Gonzalez-Espinoza, Ivan R; Huertas, Roberto M; Jara-Casas, Diego et al.
DOI: 10.1016/j.ejca.2022.12.013

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

PMID: 38106570
Journal: Kidney International Reports
Year: 2023
Reference: Kidney Int Rep. 2023 Sep 22;8(12):2754-2764. doi: 10.1016/j.ekir.2023.09.017. eCollection 2023 Dec.
Impact factor:
Publication type: Paper in international publication
Authors: Biondani, Andrea; Cavero, Teresa; Chaperon, Frederique; Daina, Erica; Eisenberger, Ute; Ettrup, Anders; Florea, Ioana; Gackler, Anja; Garcia-Carro, Clara; Jansson, Gary et al.
DOI: 10.1016/j.ekir.2023.09.017

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.

PMID: 37311468
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874-7.
Impact factor:
Publication type: Paper in international publication
Authors: Cluzeau, Thomas; Degulys, Andrius; Della Porta, Matteo Giovanni; Dimicoli-Salazar, Sophie; Fenaux, Pierre; Garcia-Manero, Guillermo; Giuseppi, Ana Carolina; Hayati, Sheida; Jonasova, Anna; Keeperman, Karen L et al.
DOI: 10.1016/S0140-6736(23)00874-7

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.

PMID: 36716407
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 May 1;41(13):2436-2445. doi: 10.1200/JCO.22.01900. Epub 2023 Jan 30.
Impact factor:
Publication type: Paper in international publication
Authors: Coleman, Robert L; Colombo, Nicoletta; Dean, Andrew; Denys, Hannelore; Esteves, Brooke; Harter, Philipp; Konner, Jason A; Lorusso, Domenica; Marin, Margarita Romeo; Matulonis, Ursula A et al.
DOI: 10.1200/JCO.22.01900

Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.

PMID: 37597162
Journal: ALLERGY
Year: 2023
Reference: Allergy. 2023 Aug 19. doi: 10.1111/all.15854.
Impact factor:
Publication type: Paper in international publication
Authors: Baron, Jens; Brehler, Randolf; Ferrer, Marta; Gimenez-Arnau, Ana Maria; Groffik, Adriane; Grundmann, Sonja; Jakob, Thilo; Labrador-Horrillo, Moises; Maurer, Marcus; Metz, Martin et al.
DOI: 10.1111/all.15854

Efficacy and Safety of Oral Factor XIa Inhibitors in Stroke Prevention: A Systematic Review and Meta-Analysis.

PMID: 37685629
Journal: Journal of Clinical Medicine
Year: 2023
Reference: J Clin Med. 2023 Aug 26;12(17):5562. doi: 10.3390/jcm12175562.
Impact factor:
Publication type: Review in international publication
Authors: Alexandrov, Andrei; Caso, Valeria; Eleftheriou, Andreas; Karapanayiotides, Theodore; Katsanos, Aristeidis H; Lemmens, Robin; Mitsias, Panayiotis D; Molina, Carlos A; Molina, Carlos A; Palaiodimou, Lina et al.
DOI: 10.3390/jcm12175562

Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.

PMID: 37923826
Journal: DIGESTIVE DISEASES AND SCIENCES
Year: 2023
Reference: Dig Dis Sci. 2023 Nov 3. doi: 10.1007/s10620-023-08155-1.
Impact factor:
Publication type: Paper in international publication
Authors: Belohlavek, Jan; Dimitrova, Emiliya; Elenski, Kiril; Etropolska, Zlatka; Jung, Christian; Petrisor, Diana Corina; Riera, Jordi; Santos, Javier et al.
DOI: 10.1007/s10620-023-08155-1

Publications